Baars, A.; Oosting, A.; Knol, J.; Garssen, J.; Van Bergenhenegouwen, J.
The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5. Microorganisms 2015, 3, 641-666.
https://doi.org/10.3390/microorganisms3040641
AMA Style
Baars A, Oosting A, Knol J, Garssen J, Van Bergenhenegouwen J.
The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5. Microorganisms. 2015; 3(4):641-666.
https://doi.org/10.3390/microorganisms3040641
Chicago/Turabian Style
Baars, Annemarie, Annemarie Oosting, Jan Knol, Johan Garssen, and Jeroen Van Bergenhenegouwen.
2015. "The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5" Microorganisms 3, no. 4: 641-666.
https://doi.org/10.3390/microorganisms3040641
APA Style
Baars, A., Oosting, A., Knol, J., Garssen, J., & Van Bergenhenegouwen, J.
(2015). The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5. Microorganisms, 3(4), 641-666.
https://doi.org/10.3390/microorganisms3040641